A detailed history of Investors Asset Management Of Georgia Inc transactions in Biogen Inc. stock. As of the latest transaction made, Investors Asset Management Of Georgia Inc holds 1,032 shares of BIIB stock, worth $163,788. This represents 0.1% of its overall portfolio holdings.

Number of Shares
1,032
Previous 1,032 -0.0%
Holding current value
$163,788
Previous $239,000 16.32%
% of portfolio
0.1%
Previous 0.12%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 01, 2023

SELL
$256.56 - $292.34 $51,312 - $58,467
-200 Reduced 16.23%
1,032 $286,000
Q3 2017

Nov 02, 2017

BUY
$281.15 - $329.69 $346,376 - $406,178
1,232
1,232 $386,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $22.9B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Investors Asset Management Of Georgia Inc Portfolio

Follow Investors Asset Management Of Georgia Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Investors Asset Management Of Georgia Inc , based on Form 13F filings with the SEC.

News

Stay updated on Investors Asset Management Of Georgia Inc with notifications on news.